These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23420447)

  • 1. Combining PCI and CABG: the role of hybrid revascularization.
    Green KD; Lynch DR; Chen TP; Zhao D
    Curr Cardiol Rep; 2013 Apr; 15(4):351. PubMed ID: 23420447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents.
    van der Heijden LC; Kok MM; Zocca P; Sen H; Löwik MM; Mariani S; de Man FHAF; Hartmann M; Stoel MG; van Houwelingen KG; Louwerenburg JHW; Linssen GCM; Doggen CJM; Grandjean JG; von Birgelen C
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid approach for coronary artery revascularization: where do we stand?
    Toeg H; Al-Atassi T; Labinaz M; Le May M; Ruel M
    Curr Opin Cardiol; 2014 Nov; 29(6):534-41. PubMed ID: 25159279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
    Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
    J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Revascularization: A Review.
    Saha T; Naqvi SY; Goldberg S
    Cardiology; 2018; 140(1):35-44. PubMed ID: 29734170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Coronary Revascularization - Current State of the Art.
    Leyvi G; Dabas A; Leff JD
    J Cardiothorac Vasc Anesth; 2019 Dec; 33(12):3437-3445. PubMed ID: 31570244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: A meta-analysis of patients with left main coronary artery disease.
    Spinthakis N; Farag M; Gorog DA; Prasad A; Mahmood H; Gue Y; Wellsted D; Nabhan A; Srinivasan M
    Int J Cardiol; 2017 Dec; 249():101-106. PubMed ID: 28958756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes of Coronary Artery Bypass Grafting Using Internal Mammary Graft Versus Percutaneous Coronary Intervention for Isolated Proximal Left Anterior Descending Narrowing.
    Iqbal MB; Ilsley C; De Robertis F; Lane R; Kabir T; Bahrami T; Simon A; Popov A; Amrani M; Dalby MC; Mason M; Grocott-Mason R; Smith RD; Raja SG
    Am J Cardiol; 2017 Mar; 119(5):719-726. PubMed ID: 28038726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registry.
    Sen H; Lam MK; Tandjung K; Löwik MM; van Houwelingen KG; Stoel MG; Louwerenburg HW; de Man FH; Linssen GC; Grandjean JG; Doggen CJ; von Birgelen C
    Int J Cardiol; 2014 Oct; 176(3):885-90. PubMed ID: 25168098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Practical Approach to Hybrid Coronary Revascularization.
    Singh T; Ayinapudi K; Motwani A; Hendel R; Le Jemtel TH
    Cardiol Rev; 2020; 28(5):240-243. PubMed ID: 31985524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CABG, stents, or hybrid procedures for left main disease?
    Kappetein AP; Head SJ
    EuroIntervention; 2015; 11 Suppl V():V111-4. PubMed ID: 25983142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Percutaneous Coronary Intervention With Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Isolated Proximal Left Anterior Descending Coronary Disease.
    Kinnaird T; Kwok CS; Narain A; Butler R; Ossei-Gerning N; Ludman P; Moat N; Anderson R; Mamas MA
    Am J Cardiol; 2016 Oct; 118(8):1171-1177. PubMed ID: 27553097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.
    Hlatky MA; Boothroyd DB; Baker LC; Go AS
    Am Heart J; 2015 Jan; 169(1):149-54. PubMed ID: 25497260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and drug-eluting stents?
    Koskinas KC; Windecker S
    Herz; 2016 May; 41(3):224-32. PubMed ID: 27048841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.